This site is not optimized for mobile devices. For the best mobile experience we suggest you download our mobile app!
Download on App Store App Store Icon App Store Google Play Store Icon Google Play

Primary Prophylaxis of OIs

According to Stage of Immunodeficiency

CD4 count threshold / indication

CD4 count < 200 cells/µL, CD4 percentage < 14%, recurrent oral thrush, or relevant concomitant immunosuppression*

Prophylaxis against Pneumocystis jirovecii Pneumonia (PcP) & Toxoplasma gondii infection

Stop: if CD4 count > 100 cells/µL and HIV-VL undetectable over 3 months

* e.g. use of corticosteroids > 20 mg prednisone equivalent per day for > 2 weeks, cancer chemotherapy, biological agents such as rituximab and others.
Decisions on initiation and discontinuation in these situations have to be taken individually

 Preferred regimen Drug / Dose Comments
Positive or negative serology for
toxoplasmosis

trimethoprim sulfamethoxazole (TMP-SMX)
80/400 mg qd po or
160/800 mg qd po or
160/800 mg x 3/week po

In case of non-severe TMP-SMX allergy and if other therapeutic options are not available/not clinically appropriated, desensitization can be attempted**
 Alternative regimens Drug / Dose Comments
Negative serology for toxoplasmosis dapsone
100 mg qd po
Check for G6PD-deficiency
atovaquone suspension
1500 mg qd (with food)
 
pentamidine
300 mg in 6 mL sterile water x 1
inhalation/month
Does not prevent the rare extrapulmonary
manifestations of P. jirovecii
Positive serology for toxoplasmosis dapsone 
200 mg/week po
+ pyrimethamine 
75 mg/week po
+ folinic acid
25-30 mg/week po
Check for G6PD-deficiency
atovaquone suspension
1500 mg qd po (with food)
+/- pyrimethamine 
75 mg/week po
+/- folinic acid
25-30 mg/week po
 
CD4 count < 100 cells/µL

Pre-emptive therapy against cryptococcal disease in individuals with:

  • positive cryptococcal serum antigen AND
  • CD4 count <100/µL AND
  • No evidence of cryptococcal meningitis or other manifestations of cryptococcal disease after thorough investigation
 Preferred regimen Dose Comments
Fluconazole

 

800 mg qd po for 2 weeks followed by

400 mg qd po for 8 weeks

Asymptomatic individual and cryptococcal meningitis, pulmonary or other site infection ruled out. See also Cryptococcal meningitis

CD4 count < 50 cells/µL
Prophylaxis against Non-Tuberculous Mycobacteria (NTM) (M. avium complex, M. genavense, M. kansasii)
Prophylaxis is not recommended if ART is started
Prophylaxis may be considered for persons with CD4 counts < 50 cells/µL who remain viremic on ART (drug resistant HIV with no option to achieve virologic control); exclude disseminated MAC disease before starting
Regimens listed are alternatives azithromycin
1200-1250 mg/week po
Check for interactions with ARVs,
see Anti-infective and ART interactions table
or
clarithromycin
500 mg bid po
  or
rifabutin
300 mg qd po

Check for interactions with ARVs,
see Anti-infective and ART interactions table

Active TB should be ruled out before starting rifabutin

** for protocols see: J. Allerg. Clin. Immunol 1994; 93:1001-1005; J Infect Dis 2001 Oct 15;184(8):992-7